You just left an ENT or audiologist appointment. Someone used words like "bone-anchored," "CROS," or "single-sided deafness," and now you have more questions than when you walked in. This guide answers all of them plainly: how these devices work, who they help, what surgery involves, how brands compare, and what everything costs.
At a Glance
| Topic | Key Facts |
|---|---|
| Primary keyword | Bone conduction hearing aid |
| Device categories | Non-surgical BCHA, surgical BAHA (percutaneous and transcutaneous), CROS, BiCROS |
| Ideal candidates | Conductive or mixed hearing loss, single-sided deafness, aural atresia, chronic ear infections |
| Not suitable for | Pure sensorineural hearing loss (unless SSD routing applies) |
| Cost range | Non-surgical: $500 to $3,000; Surgical: $9,250 to $24,700 |
| Insurance | BAHAs classified as prosthetics by most payers; Medicare generally covers; Medicaid varies by state |
| Surgery age floor | 5 years old for implant placement |
| Leading brands | Cochlear (Baha 6 Max, Osia 2), Oticon Medical (Ponto 5 Mini), MED-EL (Bonebridge, ADHEAR) |
What Is a Bone-Anchored Hearing Aid (BAHA)?
A bone-anchored hearing aid is a surgically implanted device that transmits sound through the skull bone directly to the inner ear, bypassing a damaged or absent outer and middle ear entirely.
Standard hearing aids work by amplifying sound waves that travel through the ear canal, vibrate the eardrum, and then pass through three tiny bones in the middle ear before reaching the cochlea. When any part of that pathway is damaged, absent, or blocked by chronic infection, a conventional aid has limited value. The BAHA takes a different route.
How Does Bone Conduction Work?
Sound is mechanical vibration. In normal hearing, that vibration travels through air and then through tissue. Bone conduction simply skips the air-and-eardrum phase. A small titanium implant anchored in the mastoid bone behind the ear picks up sound from an external processor and converts it into vibrations. Those vibrations travel through the skull directly to the cochlea, where the inner ear converts them to nerve signals as it normally would.
A useful analogy: imagine the cochlea is a room. A standard hearing aid enters through the front door (the ear canal). A bone conduction hearing aid knocks on the wall. The room still receives the sound either way, as long as the room itself (the cochlea and auditory nerve) is functional.
Surgical vs. Non-Surgical BAHA: Headband Options and Soft-Band Devices
Bone conduction hearing aids fall into two broad categories based on whether the device requires surgery, and the surgical category itself splits further into three implant styles.
Non-Surgical Bone Conduction Hearing Aids (BCHA)
A non-surgical bone conduction hearing aid delivers sound through skin contact rather than a titanium implant. The most common format is a softband or headband that holds a sound processor firmly against the skull, typically over the mastoid bone. Signal attenuation (loss of sound quality through the skin) is the primary tradeoff: sound transmitted through intact skin is somewhat muffled compared to direct bone contact, which is why surgical options generally deliver better clarity.
Even so, non-surgical options serve important roles. Infants and young children under age five are not candidates for implant surgery, so a softband BCHA is the standard solution for babies born with bilateral aural atresia or other structural conditions. The softband also functions as a clinical trial: audiologists often fit patients with a headband device before surgery to confirm the patient benefits from bone conduction routing before committing to a procedure.
MED-EL's ADHEAR system takes a different approach. It uses a small adhesive adapter that sticks to the skin behind the ear without a headband or skin pressure, making it the most discreet non-surgical option currently available.
Surgical Bone-Anchored Hearing Aids (BAHA): Three Implant Styles
Once a patient is a surgical candidate, three implant architectures are available.
Percutaneous implants use a titanium abutment that protrudes through the skin. The external sound processor snaps directly onto the abutment, creating the most direct bone-to-processor connection and generally the highest sound fidelity. The tradeoff is daily cleaning of the skin around the abutment site to prevent irritation or infection. Cochlear's classic Baha system and Oticon Medical's Ponto line use this design.
Passive transcutaneous implants place all hardware under the skin. The external processor attaches magnetically through intact skin, eliminating any wound to care for. Sound must pass through tissue to reach the implant, which introduces slight signal dampening compared to percutaneous designs. Cochlear's Baha Attract system follows this approach.
Active transcutaneous implants solve the signal dampening problem by moving the sound actuator itself under the skin. The implanted component converts the signal and vibrates the skull from inside, requiring no through-skin transmission after the initial wireless signal from the external unit. Cochlear's Osia 2 system and MED-EL's Bonebridge use this design. Both carry recent FDA approvals and represent the newest generation of bone conduction implant technology.
BAHA vs. Cochlear Implant: Key Differences, Candidacy, and Outcomes
A bone-anchored hearing aid and a cochlear implant are both surgical hearing devices, but they treat fundamentally different types of hearing loss and work through completely different mechanisms.
| Feature | BAHA | Cochlear Implant |
|---|---|---|
| Target loss type | Conductive, mixed, or single-sided deafness | Severe to profound sensorineural |
| Inner ear required | Must be functional | Bypasses inner ear entirely |
| Mechanism | Vibrates skull bone to stimulate cochlea | Electrode array stimulates auditory nerve directly |
| Surgery complexity | Lower (local or general anesthesia) | Higher (general anesthesia, longer procedure) |
| Rehabilitation | Minimal | Extensive auditory training required |
| Age eligibility | BCHA from birth; implant from age 5 | Cochlear implant from 12 months (FDA-approved) |
| Insurance classification | Prosthetic device | Medical device |
The clearest distinction is what each device requires of the inner ear. A BAHA sends a mechanical signal to the cochlea and depends on the cochlea to do its job. A cochlear implant replaces cochlear function by delivering electrical signals directly to the auditory nerve, bypassing a damaged cochlea altogether.
A patient with conductive hearing loss (damaged ear canal or middle ear, intact cochlea) is a BAHA candidate. A patient with severe sensorineural hearing loss (damaged cochlea or auditory nerve) is more likely a cochlear implant candidate. A patient with single-sided deafness may benefit from either, depending on residual hearing, candidacy criteria, and personal preference.
According to the National Institute on Deafness and Other Communication Disorders (NIDCD), cochlear implants are appropriate for adults with severe to profound hearing loss who receive limited benefit from conventional hearing aids. That candidacy threshold matters: many patients who "fail" conventional aids are cochlear implant candidates rather than BAHA candidates.
A formal hearing evaluation with an audiologist, and in some cases an ENT surgeon specializing in otology, is the only way to determine which device is appropriate.
What Is a CROS Hearing Aid? How It Routes Sound for Single-Sided Deafness
A CROS (Contralateral Routing of Signal) hearing aid solves a specific and frustrating problem: one ear with no usable hearing. The device captures sound from the side of the non-hearing ear and wirelessly transmits it to a receiver worn on the better ear, so the listener never misses speech or sound originating from their worse side.
CROS hearing aids do not restore hearing in the non-functioning ear. They reroute it. The better ear does all the actual hearing; the CROS system ensures that ear receives input from both sides of the head.
Single-sided deafness (SSD) creates real-world difficulties beyond simple volume: locating where sounds come from becomes unreliable, following conversation in noisy rooms is harder, and speech arriving from the deaf side is simply missed. A CROS system addresses all three by feeding both-side audio into the working ear.
CROS devices come in several physical formats. Most are discreet behind-the-ear or in-the-ear units that look nearly identical to standard hearing aids. The transmitter sits on the deaf ear; the receiver sits on the hearing ear. Many current systems from Phonak, Signia, and Oticon use Bluetooth for the wireless link, which improves latency and reduces the artificial sound quality of older FM-based systems.
Important limitation: a CROS hearing aid works only when the better ear has normal or near-normal hearing. When the better ear also has hearing loss (just less severe), a different device is needed.
BiCROS Hearing Aids: When Both Ears Have Different Levels of Loss
A BiCROS (Bilateral Microphones with Contralateral Routing of Signal) hearing aid is the solution when both ears have hearing loss, but one ear has no usable hearing at all.
The mechanism combines two functions in one system. The unit on the non-hearing ear captures sound and routes it to the better ear, exactly as a standard CROS device does. But the unit on the better ear also amplifies incoming sound for that ear, because the better ear itself has some degree of hearing loss requiring correction.
The result: the better ear receives both amplified local sound and the routed signal from the worse side.
BiCROS candidacy depends on the better ear having a measurable hearing loss that benefits from amplification. Audiologists typically evaluate this during the standard hearing assessment. Patients sometimes discover they need BiCROS rather than CROS because their "good" ear tests below normal thresholds they did not previously notice.
Cost for BiCROS systems typically runs higher than standard CROS because both units include active amplification components. Phonak's Sky and Paradise platforms, Signia's Styletto series, and Oticon's More platform all offer BiCROS configurations as of 2024.
Best CROS and BiCROS Hearing Aids in 2026: Phonak, Signia, and Oticon Compared
Three major manufacturers dominate the CROS and BiCROS category. Each brand has specific strengths, and the right choice depends on the patient's hearing profile, lifestyle, and technology preferences.
| Brand | CROS/BiCROS Models | Wireless Technology | Key Differentiator | Best For |
|---|---|---|---|---|
| Phonak | CROS P, CROS B, Sky CROS | Paradise platform, Bluetooth | AutoSense OS automatic scene detection | Active users, frequent background noise environments |
| Signia | CROS Silk X, Pure Charge&Go AX CROS | Own Voice Processing (OVP) | Reduces the tinny sound of the wearer's own voice | People bothered by how their own voice sounds through aids |
| Oticon | CROS miniRITE, More CROS | BrainHearing technology, 360-degree sound | Processes full sound environment rather than focusing directionally | Listeners who find narrow directional focus fatiguing |
BAHA Brand Comparison: Cochlear, Oticon Medical, and MED-EL
For bone-anchored hearing aids specifically, three manufacturers hold FDA approval for systems sold in the United States.
| Brand | Devices | Implant Types | Connectivity | Key Differentiator |
|---|---|---|---|---|
| Cochlear | Baha 6 Max, Baha Attract, Osia 2 | Percutaneous, passive transcutaneous, active transcutaneous | Bluetooth LE, Made for iPhone | Widest product range; only brand with all three implant architectures |
| Oticon Medical | Ponto 5 Mini, Ponto 5 SuperPower | Percutaneous only | Bluetooth, direct streaming | Smallest percutaneous processor; strong performance in high-frequency speech |
| MED-EL | Bonebridge, ADHEAR | Active transcutaneous (implant), non-surgical adhesive | Wireless streaming | ADHEAR offers surgery-free trial; Bonebridge fully implanted actuator |
No single brand is objectively best. Candidacy, audiogram profile, surgeon familiarity with the system, and personal lifestyle preferences all factor into the choice. A qualified audiologist and ENT surgeon will recommend based on individual clinical findings.
Sensorineural vs. Conductive Hearing Loss: Which Hearing Aid Type Fits Each
Matching the right device to the right hearing loss type is the central question in audiology. Getting it wrong means spending significant money on a device that does not help.
Conductive hearing loss occurs when sound cannot efficiently travel through the outer ear canal or middle ear to the cochlea. Causes include aural atresia (absent or narrowed ear canal), chronic otitis media (middle ear infections), otosclerosis (abnormal bone growth in the middle ear), or perforated eardrums. The cochlea itself is intact. Because the inner ear works correctly, a bone conduction hearing aid is often highly effective: it routes sound directly to the functional cochlea, bypassing the damaged conductive pathway entirely.
Sensorineural hearing loss (SNHL) occurs when the cochlea or auditory nerve is damaged. Causes include aging (presbycusis), noise exposure, certain medications (ototoxic drugs), genetic conditions, and viral infections. Conventional amplifying hearing aids can help with mild to moderate SNHL by making incoming sound louder. Severe to profound SNHL typically leads to cochlear implant evaluation. Bone conduction devices generally do not help pure SNHL, because vibrating the skull more strongly does not compensate for a cochlea that cannot process the signal.
Mixed hearing loss has both conductive and sensorineural components. A bone conduction device may still provide significant benefit if the sensorineural component is moderate and the conductive loss is the dominant barrier.
Single-sided deafness (SSD) is a separate category. Here, one ear is profoundly or totally deaf (often from sudden sensorineural loss, surgery, acoustic neuroma, or trauma) while the other ear is normal. Both CROS hearing aids and BAHAs can help SSD patients. The BAHA routes sound to the intact cochlea of the better ear through bone conduction. The CROS system routes it wirelessly through the air to a receiver at the better ear. Which approach works better varies by patient preference and audiological factors.
"For adults with single-sided deafness, both CROS hearing aids and bone-anchored hearing aids have demonstrated benefit in speech understanding in noise compared to unaided listening." Source: American Academy of Otolaryngology, Head and Neck Surgery clinical guidance
Getting Assessed: Audiogram, Candidacy Criteria, and Finding a Specialist
The path to a bone conduction hearing aid or CROS device begins with a comprehensive hearing evaluation, and not all hearing tests are equal for this purpose.
Step 1: Pure Tone Audiometry
A standard audiogram measures how well a person hears tones at different frequencies and volumes. For bone conduction candidacy, the audiologist performs both air conduction testing (standard headphones) and bone conduction testing (a small oscillator placed on the mastoid bone). Comparing the two results reveals the "air-bone gap," which is the core diagnostic indicator of conductive hearing loss.
A significant air-bone gap at multiple frequencies is the primary signal that a bone conduction pathway is intact and a BAHA may help.
Step 2: Speech Discrimination Testing
Pure tones tell the audiologist how loud sound needs to be. Speech testing tells them how well the patient processes spoken words. Candidates for bone-anchored devices need adequate speech discrimination scores in the better ear, because all hearing ultimately routes there.
Step 3: Candidacy Assessment and Imaging
For surgical BAHA candidates, an ENT surgeon typically orders a CT scan of the temporal bone to confirm adequate bone thickness for implant placement. The minimum bone thickness for standard percutaneous implants is approximately 3 mm for adults; children typically reach adequate thickness by age 5, which is why surgery is generally not performed before that age.
Non-surgical candidates (CROS, BiCROS, softband BCHA) can be fitted without imaging.
Step 4: Non-Surgical Trial
Most audiologists offer an in-clinic trial with a softband or test-band device before committing to anything surgical. This step confirms that the patient genuinely benefits from bone conduction routing. Patients who do not experience improvement during the trial are unlikely to benefit from the implant.
If you are ready to move toward formal evaluation, finding an ENT or audiologist who specializes in bone conduction devices is the right starting point. A specialist can review your audiogram, discuss surgical vs. non-surgical options, and coordinate any imaging needed before a recommendation.
How Much Does a Bone Conduction Hearing Aid Cost?
Bone conduction implants typically cost between $9,250 and $24,700 all-in, depending on the device type, facility fees, and geographic location.
To be more specific: percutaneous BAHA systems average around $11,600 when factoring in device, surgical facility, and audiologist programming costs, with a range of approximately $9,250 to $21,900. Transcutaneous systems, including passive magnetic and active transcutaneous designs, tend to cost slightly more, averaging around $13,850 with a range of $10,700 to $24,700. These figures reflect total out-of-pocket exposure before insurance, not device cost alone.
Non-surgical options are considerably less expensive. Softband systems typically range from $500 to $3,000 depending on the processor model and fitting fees. The MED-EL ADHEAR system falls within the lower end of this range.
Cost drivers include the processor model (flagship models with full Bluetooth streaming cost more than base models), facility type (hospital-based surgical centers cost more than outpatient clinics), surgeon experience, and region of the country. Processor replacement follows a roughly 5-year cycle; the implant itself is permanent. Budget for processor upgrades when planning long-term costs.
Does Insurance Cover Bone Conduction Hearing Aids?
Most insurance payers classify BAHAs as prosthetic devices rather than hearing aids, which matters significantly for coverage. Standard hearing aid exclusions in many insurance plans do not apply to BAHAs under this classification.
Medicare generally covers bone-anchored hearing aids under Part B as prosthetic devices when medical necessity criteria are met. Prior authorization is typically required. Coverage does not automatically extend to the sound processor replacement on the standard 5-year cycle; a new medical necessity letter may be needed.
Medicaid coverage varies by state. Most states cover BAHAs for pediatric patients. Adult coverage depends on the state's specific benefit structure and requires prior authorization with ENT documentation in virtually all cases.
Commercial insurance plans vary widely. Many cover BAHAs under the medical benefit (not the hearing benefit, which often has low caps or exclusions). The CPT code for BAHA implantation is 69714 (percutaneous) and 69716 (transcutaneous); confirming that the plan covers these specific codes with the insurer's benefits department before scheduling is a practical first step.
Practical steps for insurance navigation: Call the member services number on the insurance card and ask specifically whether CPT codes 69714 and 69716 are covered under the medical benefit. Request that the ENT office submit a letter of medical necessity before surgery is scheduled. If the plan has a hearing aid exclusion, ask whether that exclusion applies to osseointegrated bone-anchored devices classified as prosthetics, because the answer is often no.
CROS and BiCROS hearing aids follow standard hearing aid insurance rules, which means coverage is frequently limited or absent in commercial plans, though some states have hearing aid coverage mandates.
Bone Conduction Hearing Aids vs. Bone Conduction Headphones: What Is the Difference?
Consumer bone conduction headphones, most visibly the Shokz (formerly AfterShokz) brand, use the same physical principle as medical bone conduction devices but serve an entirely different purpose.
Consumer bone conduction headphones sit on the cheekbones or temples and transmit music or podcast audio through the skull, leaving the ear canal open for ambient sound. They are designed for runners, cyclists, and others who want audio without blocking environmental sounds. They are not amplified to hearing aid specifications, not calibrated to an audiogram, not prescribed by a clinician, and they are not medical devices. They treat no hearing condition.
A person with documented hearing loss who buys consumer bone conduction headphones hoping to improve their hearing will be disappointed. The volume output is engineered for music enjoyment by people with normal hearing, not to compensate for a measured hearing deficit.
The key sorting question: if a formal audiogram shows hearing loss and a clinician has recommended a bone conduction device, the answer is a medical BCHA or BAHA, not a consumer product. If someone wants to listen to podcasts while running without earbuds, a consumer product is fine.
What to Expect: The Patient Journey From Diagnosis to First Sound
The timeline from first appointment to active hearing with a bone-anchored device typically spans three to five months for surgical cases, less for non-surgical fittings.
Audiological evaluation (Week 1 to 2). A full audiogram including bone conduction testing establishes candidacy. A speech discrimination test confirms the better ear can process sound adequately.
ENT consultation and candidacy confirmation (Week 2 to 4). The ENT surgeon reviews the audiogram, discusses device options, and orders a CT scan if surgery is being considered.
Non-surgical trial (Week 3 to 6). The audiologist fits a softband or test-band device for home use. This trial typically runs two to four weeks and gives the patient real-world experience with bone conduction routing before committing to surgery.
Surgery scheduling and procedure (Week 6 to 10, for surgical candidates). BAHA surgery is typically performed under local anesthesia with sedation in adults and general anesthesia in children. The procedure usually takes 30 to 60 minutes. Most patients go home the same day.
Osseointegration period (Week 10 to 20). The titanium implant fuses with the skull bone over 4 to 12 weeks, depending on the patient's age and bone density. The external processor is not attached during this phase.
Device activation and audiologist tuning (Month 3 to 5). Once the implant has fully integrated, the audiologist attaches the sound processor and programs it to the patient's audiogram. Multiple tuning appointments over the following weeks are standard.
Ongoing follow-up. Annual audiological monitoring and periodic processor adjustments are routine. For percutaneous implant wearers, regular wound site checks are also part of follow-up care.
For non-surgical patients (CROS, BiCROS, softband BCHA), the journey is considerably shorter: evaluation, fitting, and programming can often occur within two to three appointments over two to four weeks.
Life With a Bone Conduction Hearing Aid: Practical Answers
Swimming and showering. Most sound processors are rated for moisture resistance but not full submersion. Cochlear's Baha 6 Max, Oticon's Ponto 5, and MED-EL's Bonebridge processor carry IP68 ratings allowing up to 3 meters of water depth for 30 minutes. Always verify the specific model's water rating before swimming. The implant itself has no water restrictions once fully healed.
MRI compatibility. The titanium implant is generally safe in 1.5 Tesla MRI environments; confirm with the implant manufacturer and the imaging center before scheduling. For passive transcutaneous systems with a magnetic implant component, the magnet may need to be temporarily removed before MRI. The external sound processor must always be removed before entering the MRI room.
Sleeping. The external processor is removed for sleep. For percutaneous implant wearers, the abutment remains in place during sleep; no special management is required. For non-surgical softband users, the headband is simply removed.
Abutment care (percutaneous implants only). Daily cleaning of the skin around the abutment with a soft brush and mild soap is standard. Mild skin reactions at the abutment site are common in the first months after surgery. Persistent redness, swelling, or discharge warrants contact with the ENT team.
Device lifespan. The implanted titanium component is designed to be permanent. The external sound processor has a functional lifespan of approximately five years before it typically requires replacement, though many patients upgrade sooner as newer processor generations with improved sound processing and connectivity become available.
Tinnitus. Some bone conduction hearing aid users report improvement in tinnitus perception as a secondary benefit of improved auditory input. This is not a primary indication and results vary. Audiologists can discuss whether a bone conduction trial is appropriate for patients whose tinnitus accompanies documented hearing loss.
Frequently Asked Questions
What is the difference between a BAHA and a BCHA?
A BCHA (bone conduction hearing aid) is the broader category: any device that transmits sound through bone vibration. A BAHA (bone-anchored hearing aid) is specifically a BCHA that uses a surgically implanted titanium anchor. All BAHAs are BCHAs, but not all BCHAs are BAHAs. Non-surgical softband devices and adhesive devices like the ADHEAR are BCHAs that do not require surgery.
What is a CROS hearing aid and who needs one?
A CROS hearing aid captures sound from a deaf or non-functional ear and wirelessly routes it to a receiver on the better ear, so the better ear hears input from both sides. It is designed for people with single-sided deafness whose better ear has normal or near-normal hearing. People whose better ear also has hearing loss are typically fitted with a BiCROS system, which adds amplification to the better ear's unit.
What is the difference between CROS and BiCROS hearing aids?
CROS routes sound from the non-hearing ear to a normal-hearing ear. BiCROS routes sound from the non-hearing ear to an ear that also has hearing loss, combining signal routing with amplification in the better-ear unit. The distinction depends entirely on whether the better ear has measurable hearing loss requiring correction.
Can you get a bone conduction hearing aid without surgery?
Yes. Softband systems hold a bone conduction processor against the skull using a headband. The MED-EL ADHEAR attaches with an adhesive adapter, with no headband and no surgery. Non-surgical options involve some signal attenuation compared to surgical implants, but they are fully functional and are the standard approach for children under five who are not yet eligible for surgery.
What is the difference between a cochlear implant and a hearing aid?
A conventional hearing aid amplifies sound for a partially functioning ear. A cochlear implant bypasses a non-functioning cochlea entirely by delivering electrical signals directly to the auditory nerve through an electrode array. Cochlear implants require surgery and significant auditory rehabilitation. They are indicated for severe to profound sensorineural hearing loss when hearing aids provide insufficient benefit. Bone-anchored hearing aids, by contrast, depend on a functional cochlea and are used for conductive or mixed hearing loss and single-sided deafness.
Can children get bone conduction hearing aids?
Yes. Non-surgical softband systems are fitted from birth for infants with conditions like bilateral aural atresia. Surgical implant placement is generally not recommended before age five, when the skull has grown enough for reliable osseointegration. For children between birth and age five, softband systems provide bone conduction benefit while monitoring skull development for future surgical candidacy.
Making Your Next Step Easier
Navigating device categories, insurance codes, and specialist referrals takes time. If you want to explore your options further, the Momentary Lab AI healthcare navigator can help you understand the hearing care pathway, identify the right questions to ask at your next appointment, and point you toward appropriate resources.
